TLRY
Tilray Brands, Inc. NASDAQ Listed Jul 19, 2018$5.66
Mkt Cap $677.0M
52w Low $3.50
11.0% of range
52w High $23.20
50d MA $6.79
200d MA $9.76
P/E (TTM)
-0.2x
EV/EBITDA
-0.2x
P/B
0.3x
Debt/Equity
0.2x
ROE
-91.4%
P/FCF
-2.2x
RSI (14)
—
ATR (14)
—
Beta
2.11
50d MA
$6.79
200d MA
$9.76
Avg Volume
4.1M
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
265 Talbot Street West · Leamington, ON N8H 5L4 · CA
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | AMC | -0.14 | -0.24 | -71.4% | 6.14 | -1.1% | +6.7% | +1.7% | -3.0% | +4.5% | -0.4% | — |
| Jan 8, 2026 | AMC | -0.14 | -0.41 | -192.9% | 9.13 | +10.1% | +0.5% | +1.3% | +1.0% | +5.4% | -1.9% | — |
| Oct 9, 2025 | AMC | -0.27 | -0.00 | +98.4% | 21.00 | -4.3% | -18.1% | -1.7% | -5.3% | +5.0% | -8.3% | — |
| Jul 28, 2025 | AMC | -0.03 | 0.02 | +166.7% | 7.00 | -14.3% | -17.6% | +6.1% | -5.1% | -2.1% | +6.9% | — |
| Apr 8, 2025 | AMC | -0.04 | -0.10 | -150.0% | 4.56 | -1.5% | +16.2% | -4.7% | -3.6% | +0.0% | -2.9% | — |
| Jan 10, 2025 | AMC | -0.04 | -0.10 | -150.0% | 12.30 | -2.4% | -4.1% | +0.0% | +0.0% | +0.0% | +1.7% | — |
| Oct 10, 2024 | AMC | -0.04 | -0.04 | -11.1% | 15.90 | -0.6% | +2.5% | -2.5% | -1.3% | +0.6% | -0.6% | — |
| Jul 29, 2024 | AMC | -0.02 | -0.04 | -81.8% | 18.30 | +10.9% | +9.8% | +1.0% | -2.0% | -6.5% | -7.0% | — |
| Apr 9, 2024 | AMC | -0.05 | -0.12 | -140.0% | 20.60 | -4.4% | -1.9% | -5.9% | -4.2% | -2.2% | +2.8% | — |
| Jan 9, 2024 | AMC | -0.06 | -0.07 | -11.7% | 21.10 | +0.0% | -5.2% | -5.0% | -1.6% | +11.8% | -1.4% | — |
| Oct 4, 2023 | AMC | -0.05 | -0.10 | -100.0% | 22.20 | +0.0% | -4.5% | -2.8% | -1.5% | +4.9% | -3.8% | — |
| Jul 26, 2023 | AMC | -0.05 | -0.15 | -200.0% | 19.30 | +4.7% | +10.9% | +6.1% | +11.5% | -5.9% | -0.4% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 2 | Roth Capital | Upgrade | Neutral → Buy | — | $6.14 | $6.07 | -1.1% | +6.7% | +1.7% | -3.0% | +4.5% | -0.4% |
| Mar 30 | TD Cowen | Maintains | Buy → Buy | — | $6.32 | $6.32 | +0.0% | -5.2% | +8.0% | -5.1% | +6.7% | +1.7% |
| Jan 20 | Roth Capital | Maintains | Neutral → Neutral | — | $9.46 | $9.00 | -4.9% | -7.5% | -0.9% | +5.3% | -0.9% | -3.5% |
| Aug 25 | Jefferies | Maintains | Buy → Buy | — | $11.50 | $12.50 | +8.7% | +20.9% | +4.3% | -5.5% | +7.3% | -6.1% |
| Jul 29 | Zelman & Assoc | Maintains | Neutral → Neutral | — | $7.00 | $6.00 | -14.3% | -17.6% | +6.1% | -5.1% | -2.1% | +6.9% |
| Apr 9 | Piper Sandler | Maintains | Neutral → Neutral | — | $4.56 | $4.49 | -1.5% | +16.2% | -4.7% | -3.6% | +0.0% | -2.9% |
| Oct 11 | Roth MKM | Maintains | Neutral → Neutral | — | $15.90 | $15.80 | -0.6% | +2.5% | -2.5% | -1.3% | +0.6% | -0.6% |
| Apr 10 | CIBC | Maintains | Neutral → Neutral | — | $20.60 | $19.70 | -4.4% | -1.9% | -5.9% | -4.2% | -2.2% | +2.8% |
| Sep 1 | Roth MKM | Maintains | Neutral → Neutral | — | $29.60 | $30.70 | +3.7% | +1.0% | +3.3% | -3.6% | -0.7% | +2.0% |
| Apr 11 | TD Cowen | Maintains | Outperform → Outperform | — | $27.40 | $25.80 | -5.8% | -8.0% | -2.4% | -0.4% | -3.3% | +5.5% |
| Jan 10 | Alliance Global Partners | Maintains | Neutral → Neutral | — | $27.60 | $27.40 | -0.7% | +1.1% | +9.0% | +8.2% | -3.6% | +2.2% |
| Oct 10 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $31.70 | $31.50 | -0.6% | -3.2% | -5.5% | +6.2% | +5.8% | -3.7% |
| Sep 30 | Barclays | Maintains | Underweight → Underweight | — | $28.60 | $28.40 | -0.7% | -3.8% | +4.4% | +4.5% | -0.7% | +30.9% |
| Aug 2 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $34.20 | $34.20 | +0.0% | +14.0% | -0.5% | +3.9% | -3.2% | +10.3% |
| Jul 29 | Benchmark | Downgrade | Hold → Sell | — | $36.50 | $34.80 | -4.7% | +0.0% | -6.3% | +14.0% | -0.5% | +3.9% |
| Jul 15 | Roth Capital | Maintains | Neutral → Neutral | — | $36.90 | $36.40 | -1.4% | -10.6% | +3.0% | +4.7% | +10.7% | -4.8% |
| Jun 24 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $35.80 | $36.50 | +2.0% | +0.8% | +0.8% | -5.5% | -3.8% | -5.7% |
| Jun 15 | Canaccord Genuity | Maintains | Buy → Buy | — | $31.60 | $31.90 | +0.9% | +1.3% | -2.8% | +2.9% | +2.2% | -1.8% |
| Jun 15 | Piper Sandler | Maintains | Neutral → Neutral | — | $31.60 | $31.90 | +0.9% | +1.3% | -2.8% | +2.9% | +2.2% | -1.8% |
| Apr 20 | Barclays | Maintains | Underweight → Underweight | — | $58.30 | $57.60 | -1.2% | -7.2% | -3.1% | +0.0% | +1.1% | -4.3% |
| Apr 7 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $72.50 | $71.20 | -1.8% | -10.6% | -1.2% | -0.5% | -2.2% | +3.0% |
| Mar 17 | Piper Sandler | Maintains | Neutral → Neutral | — | $53.30 | $52.10 | -2.3% | +1.5% | +1.8% | -3.4% | +6.8% | +0.7% |
| Mar 4 | Canaccord Genuity | Upgrade | Hold → Buy | — | $54.20 | $54.80 | +1.1% | -3.3% | -2.3% | +3.5% | +3.8% | -1.5% |
| Jan 11 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $72.90 | $69.60 | -4.5% | +1.2% | -3.1% | -3.9% | -0.1% | -8.3% |
| Jan 7 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $64.40 | $65.10 | +1.1% | -0.3% | +13.6% | +1.2% | -3.1% | -3.9% |
| Nov 1 | Cantor Fitzgerald | Downgrade | Overweight → Neutral | — | $103.00 | $102.40 | -0.6% | +4.4% | -3.1% | +4.2% | -0.5% | -1.0% |
| Oct 8 | CIBC | Maintains | Neutral → Neutral | — | $110.20 | $108.50 | -1.5% | -4.8% | -3.1% | +1.2% | +0.1% | +1.0% |
| Sep 17 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $120.10 | $120.00 | -0.1% | +1.3% | -7.7% | -0.1% | +3.7% | +3.4% |
| Jul 27 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $137.00 | $134.90 | -1.5% | -7.1% | +25.8% | -3.7% | -5.3% | +0.0% |
| Jun 11 | CIBC | Downgrade | Outperform → Neutral | — | $200.50 | $199.00 | -0.7% | -0.8% | -3.7% | -6.2% | +0.8% | -3.6% |
| May 7 | Jefferies | Upgrade | Underperform → Buy | — | $141.50 | $153.00 | +8.1% | +14.3% | -7.0% | +4.1% | -7.2% | -5.8% |
| Feb 18 | Benchmark | Downgrade | Buy → Hold | — | $315.10 | $331.00 | +5.0% | -14.0% | +7.8% | -10.0% | -5.7% | +12.9% |
| Feb 18 | Piper Sandler | Downgrade | Overweight → Neutral | — | $315.10 | $331.00 | +5.0% | -14.0% | +7.8% | -10.0% | -5.7% | +12.9% |
| Feb 16 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $290.00 | $309.90 | +6.9% | +19.4% | -9.0% | -14.0% | +7.8% | -10.0% |
| Jan 15 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $185.60 | $215.80 | +16.3% | +6.1% | +2.0% | -6.5% | -4.6% | +0.6% |
| Dec 17 | Stifel | Upgrade | Sell → Hold | — | $93.30 | $93.50 | +0.2% | -4.0% | -0.8% | -5.6% | +0.8% | +5.1% |
| Nov 16 | Jefferies | Downgrade | Hold → Underperform | — | $76.50 | $75.00 | -2.0% | -4.3% | -1.5% | -1.1% | -5.6% | +9.4% |
| Nov 11 | Stifel | Downgrade | Hold → Sell | — | $83.30 | $77.70 | -6.7% | -3.5% | -8.0% | +3.4% | -4.3% | -1.5% |
| Nov 10 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $101.00 | $93.10 | -7.8% | -17.5% | -3.5% | -8.0% | +3.4% | -4.3% |
| Sep 21 | Jefferies | Upgrade | Underperform → Hold | — | $53.40 | $52.60 | -1.5% | -6.4% | +7.4% | -12.5% | +1.1% | +0.8% |
| Aug 11 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $79.70 | $71.40 | -10.4% | -13.0% | -0.4% | +2.2% | +2.8% | -2.6% |
| May 12 | Stifel | Maintains | Hold → Hold | — | $80.80 | $77.60 | -4.0% | -7.5% | -3.7% | -0.3% | +8.4% | +2.4% |
| May 12 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $80.80 | $77.60 | -4.0% | -7.5% | -3.7% | -0.3% | +8.4% | +2.4% |
| May 11 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $77.80 | $80.00 | +2.8% | +3.9% | -7.5% | -3.7% | -0.3% | +8.4% |
| Apr 16 | Jefferies | Downgrade | Hold → Underperform | — | $67.90 | $65.10 | -4.1% | -6.2% | +2.0% | +4.0% | +0.0% | +0.6% |
| Mar 16 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $40.30 | $35.50 | -11.9% | -24.3% | -4.9% | -14.8% | +55.9% | -5.2% |
| Mar 3 | Eight Capital | Downgrade | Buy → Neutral | — | $153.50 | $130.00 | -15.3% | -15.2% | -3.9% | -10.5% | -10.5% | -23.5% |
| Mar 3 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $153.50 | $130.00 | -15.3% | -15.2% | -3.9% | -10.5% | -10.5% | -23.5% |
| Mar 2 | Cantor Fitzgerald | Maintains | Neutral → Neutral | — | $144.30 | $147.40 | +2.1% | +6.4% | -15.2% | -3.9% | -10.5% | -10.5% |
| Feb 24 | Cowen & Co. | Downgrade | Outperform → Market Perform | — | $193.70 | $179.80 | -7.2% | -10.7% | -4.2% | -4.1% | -8.5% | -0.8% |
No insider trades available.
8-K · 5.02
!!! Very High
Onconetix, Inc. -- 8-K 5.02: Executive Change
Onconetix named Sammy Dorf as Chairman while removing Andrew Oakley and Thomas Meier from that role, also adding Josh Epstein as director in a leadership restructuring.
Apr 24
8-K · 8.01
!! High
Tilray Brands, Inc. -- 8-K 8.01: Material Event / Announcement
Tilray Brands filed a Form 8-K to register an exhibit with the SEC, likely supporting a pending registration statement for securities issuance or corporate transaction.
Apr 21
8-K
Unknown — 8-K Filing
Unable to provide analysis: the filing summary lacks substantive business information required to assess material implications for Tilray's stock price or investor position.
Apr 15
8-K · 1.01
!! High
Unknown — 8-K 1.01: Material Agreement
Tilray likely secured financing or banking services from Jefferies to fund operations or strategic initiatives, which could strengthen its financial flexibility and signal confidence from a major investment bank.
Apr 15
8-K
Unknown — 8-K Filing
Tilray's record revenue and gross profit growth signals improving operational efficiency and market traction, but the minimal $3.5M net cash position raises serious concerns about liquidity and financial runway for a cannabis company facing ongoing industry headwinds.
Apr 1
8-K · 2.01
!!! Very High
Tilray Brands, Inc. -- 8-K 2.01: Acquisition Completed
Tilray completed a significant acquisition, which could expand market share and revenue streams but carries integration risks that may pressure near-term profitability and dilute existing shareholder value.
Mar 2
Data updated apr 27, 2026 4:58am
· Source: massive.com